重磅!医保定点药店纳入省级药品集采

2019-05-17 佚名 赛柏蓝

一省,民营医院、医保定点药店接入省级药品集采。

昨日(5月15日),山东省药品集中采购网发布文件《关于民营医药机构试行网上药品集中采购的意见》(以下简称《意见》)。

▍7月1日,执行《意见》要求医疗保险协议管理的民营医疗机构、连锁零售药店,通过山东省药品集中采购平台网上采购药品。

同时,对于属于医保基金结算的药品,实际销售价格高于采购平台中标或挂网价的,医保将按照不高于采购平台中标和挂网价给予支付。

文件规定,医疗保险协议管理民营医疗机构、连锁零售药店(协议医药机构)可以通过山东省药品集中采购平台网上采购药品,?6月1日开始在公共交易中心申请开户,7月1日正式执行。

▍药品采购总量不低于原使用量的60%

《意见》要求建立价格联动机制,申请参加网上采购的协议医疗机构通过网上采购的医保目录内药品(不含中药饮片)品规总量原则上不低于本单位使用(销售)的基本医疗保险目录内药品品规总量的60%。

此外,药品采购价格由协议医药机构与生产经营企业自主议价成交,属于医保基金结算的药品,实际销售价格高于采购平台中标或挂网价的,医保按照不高于采购平台中标或挂网价给予支付,具体医保费用结算办法由各市制定。

▍民营医院、连锁药店纳入药品集采的线索

这份《意见》由山东省医保局、省卫健委、省市场监管局、省公共资源交易中心四部门发出。四部门的职能在去年大部制改革后,均有不小的调整。

其中,最引人关注、影响最深远的就是国家医保局。新成立的医疗保障局合并了人保部的城镇职工和城镇居民基本医疗保险、生育保险职责;原属于卫计委的新农合职责;民政部的医疗救助职责;发改委的药品和医疗服务价格管理;药品和耗材的招标采购职责;还有权监管医保类医疗服务行为和收费;同时将其征收医保、生育保险费用的职责交给税务部门负责。

此次机构改革之后,国家医疗保障局实现“三保合一”,一跃成为最大采购方。此外,发改委药品和医疗价格管理职责被纳入医保局。也就是说,最大的医疗服务和药品购买支付方,有权力决定药品和医疗价格。

大部制改革前,药品招标采购由卫计委下辖的招采部门主导,大部制改革后,药品招标采购的职能由新组建的国家医保局接手,一段时间以来,多地均传出,省医保局接管药品招采的消息。

有分析指出,所有的医保定点单位均纳入药品集中采购在预料之中。

▍所有医保定点单位或都纳入药品集采

早在2017年4月份,福建省医疗保障管理委员会办公室发布《关于医保定点非公立医疗机构执行药品(耗材)联合限价阳光采购有关问题的通知》,要求全省范围内所有定点医疗机构执行以医保支付结算价为基础的药品联合限价阳光采购;医保定点的所有非公立医疗机构全面实行“零差率”销售,并参照执行同级别公立医疗机构医疗服务项目的医保支付标准。

今年2月,“4+7”试点城市西安发布《西安市人民政府办公厅关于印发落实国家组织药品集中采购和使用试点工作实施方案的通知》,明确全市各级公立医疗机构全面执行国家组织药品集中采购结果,同步执行医保支付标准,并鼓励社会资本举办的医疗机构参与国家组织药品集中采购试点工作。

3月25日,西安大兴医院(民营医院)便按照规定开出了仅为6.6元/盒(7片/20mg/盒)的阿托伐他汀钙片处方,这也是国内第一张由民营医院开出的“4+7”药品处方。

无论是福建阳光采购还是西安的4+7都可以看到,无论是公立还是非公立,只要是医保定点机构,相关部门均鼓励其纳入药品集采。

既然医保局主管药品招标采购,只要是医保局出钱的医保定点单位,医保局均可以主导实行药品集中采购。

有分析指出,随着各省医保局的组建、挂牌、并行使医保和药品招标采购职能,山东的这一形势将会逐渐扩展至全国——未来在医保局管辖范围内的各类医疗机构包括民营医院、连锁零售药店等都将统一纳入到药品集中采购。

也有分析认为,零售药店纳入药品集采,有利于压缩零售药店的采购成本,加强对于医保定点药店的管理。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1748011, encodeId=a29c1e480115b, content=<a href='/topic/show?id=18ab33841b2' target=_blank style='color:#2F92EE;'>#医保定点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33841, encryptionId=18ab33841b2, topicName=医保定点)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a1836003947, createdName=Eleven23, createdTime=Sat Feb 01 08:42:00 CST 2020, time=2020-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1735514, encodeId=b8fb1e35514d6, content=<a href='/topic/show?id=6fe998e4074' target=_blank style='color:#2F92EE;'>#集采#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98740, encryptionId=6fe998e4074, topicName=集采)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=969d33912216, createdName=xsm929, createdTime=Wed Mar 25 04:42:00 CST 2020, time=2020-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1345993, encodeId=146e13459933f, content=<a href='/topic/show?id=07538e56244' target=_blank style='color:#2F92EE;'>#药店#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87562, encryptionId=07538e56244, topicName=药店)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=循证小兵, createdTime=Sun May 19 12:42:00 CST 2019, time=2019-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1416535, encodeId=61d51416535e0, content=<a href='/topic/show?id=c6a98e51396' target=_blank style='color:#2F92EE;'>#药品集采#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87513, encryptionId=c6a98e51396, topicName=药品集采)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=500a3204386, createdName=songbq, createdTime=Sun May 19 12:42:00 CST 2019, time=2019-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1549472, encodeId=f75a15494e26a, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96000, encryptionId=f7879600061, topicName=重磅)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acc14121561, createdName=xxxx1054, createdTime=Sun May 19 12:42:00 CST 2019, time=2019-05-19, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1748011, encodeId=a29c1e480115b, content=<a href='/topic/show?id=18ab33841b2' target=_blank style='color:#2F92EE;'>#医保定点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33841, encryptionId=18ab33841b2, topicName=医保定点)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a1836003947, createdName=Eleven23, createdTime=Sat Feb 01 08:42:00 CST 2020, time=2020-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1735514, encodeId=b8fb1e35514d6, content=<a href='/topic/show?id=6fe998e4074' target=_blank style='color:#2F92EE;'>#集采#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98740, encryptionId=6fe998e4074, topicName=集采)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=969d33912216, createdName=xsm929, createdTime=Wed Mar 25 04:42:00 CST 2020, time=2020-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1345993, encodeId=146e13459933f, content=<a href='/topic/show?id=07538e56244' target=_blank style='color:#2F92EE;'>#药店#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87562, encryptionId=07538e56244, topicName=药店)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=循证小兵, createdTime=Sun May 19 12:42:00 CST 2019, time=2019-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1416535, encodeId=61d51416535e0, content=<a href='/topic/show?id=c6a98e51396' target=_blank style='color:#2F92EE;'>#药品集采#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87513, encryptionId=c6a98e51396, topicName=药品集采)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=500a3204386, createdName=songbq, createdTime=Sun May 19 12:42:00 CST 2019, time=2019-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1549472, encodeId=f75a15494e26a, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96000, encryptionId=f7879600061, topicName=重磅)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acc14121561, createdName=xxxx1054, createdTime=Sun May 19 12:42:00 CST 2019, time=2019-05-19, status=1, ipAttribution=)]
    2020-03-25 xsm929
  3. [GetPortalCommentsPageByObjectIdResponse(id=1748011, encodeId=a29c1e480115b, content=<a href='/topic/show?id=18ab33841b2' target=_blank style='color:#2F92EE;'>#医保定点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33841, encryptionId=18ab33841b2, topicName=医保定点)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a1836003947, createdName=Eleven23, createdTime=Sat Feb 01 08:42:00 CST 2020, time=2020-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1735514, encodeId=b8fb1e35514d6, content=<a href='/topic/show?id=6fe998e4074' target=_blank style='color:#2F92EE;'>#集采#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98740, encryptionId=6fe998e4074, topicName=集采)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=969d33912216, createdName=xsm929, createdTime=Wed Mar 25 04:42:00 CST 2020, time=2020-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1345993, encodeId=146e13459933f, content=<a href='/topic/show?id=07538e56244' target=_blank style='color:#2F92EE;'>#药店#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87562, encryptionId=07538e56244, topicName=药店)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=循证小兵, createdTime=Sun May 19 12:42:00 CST 2019, time=2019-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1416535, encodeId=61d51416535e0, content=<a href='/topic/show?id=c6a98e51396' target=_blank style='color:#2F92EE;'>#药品集采#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87513, encryptionId=c6a98e51396, topicName=药品集采)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=500a3204386, createdName=songbq, createdTime=Sun May 19 12:42:00 CST 2019, time=2019-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1549472, encodeId=f75a15494e26a, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96000, encryptionId=f7879600061, topicName=重磅)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acc14121561, createdName=xxxx1054, createdTime=Sun May 19 12:42:00 CST 2019, time=2019-05-19, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1748011, encodeId=a29c1e480115b, content=<a href='/topic/show?id=18ab33841b2' target=_blank style='color:#2F92EE;'>#医保定点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33841, encryptionId=18ab33841b2, topicName=医保定点)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a1836003947, createdName=Eleven23, createdTime=Sat Feb 01 08:42:00 CST 2020, time=2020-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1735514, encodeId=b8fb1e35514d6, content=<a href='/topic/show?id=6fe998e4074' target=_blank style='color:#2F92EE;'>#集采#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98740, encryptionId=6fe998e4074, topicName=集采)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=969d33912216, createdName=xsm929, createdTime=Wed Mar 25 04:42:00 CST 2020, time=2020-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1345993, encodeId=146e13459933f, content=<a href='/topic/show?id=07538e56244' target=_blank style='color:#2F92EE;'>#药店#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87562, encryptionId=07538e56244, topicName=药店)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=循证小兵, createdTime=Sun May 19 12:42:00 CST 2019, time=2019-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1416535, encodeId=61d51416535e0, content=<a href='/topic/show?id=c6a98e51396' target=_blank style='color:#2F92EE;'>#药品集采#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87513, encryptionId=c6a98e51396, topicName=药品集采)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=500a3204386, createdName=songbq, createdTime=Sun May 19 12:42:00 CST 2019, time=2019-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1549472, encodeId=f75a15494e26a, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96000, encryptionId=f7879600061, topicName=重磅)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acc14121561, createdName=xxxx1054, createdTime=Sun May 19 12:42:00 CST 2019, time=2019-05-19, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1748011, encodeId=a29c1e480115b, content=<a href='/topic/show?id=18ab33841b2' target=_blank style='color:#2F92EE;'>#医保定点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33841, encryptionId=18ab33841b2, topicName=医保定点)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a1836003947, createdName=Eleven23, createdTime=Sat Feb 01 08:42:00 CST 2020, time=2020-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1735514, encodeId=b8fb1e35514d6, content=<a href='/topic/show?id=6fe998e4074' target=_blank style='color:#2F92EE;'>#集采#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98740, encryptionId=6fe998e4074, topicName=集采)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=969d33912216, createdName=xsm929, createdTime=Wed Mar 25 04:42:00 CST 2020, time=2020-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1345993, encodeId=146e13459933f, content=<a href='/topic/show?id=07538e56244' target=_blank style='color:#2F92EE;'>#药店#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87562, encryptionId=07538e56244, topicName=药店)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=循证小兵, createdTime=Sun May 19 12:42:00 CST 2019, time=2019-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1416535, encodeId=61d51416535e0, content=<a href='/topic/show?id=c6a98e51396' target=_blank style='color:#2F92EE;'>#药品集采#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87513, encryptionId=c6a98e51396, topicName=药品集采)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=500a3204386, createdName=songbq, createdTime=Sun May 19 12:42:00 CST 2019, time=2019-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1549472, encodeId=f75a15494e26a, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96000, encryptionId=f7879600061, topicName=重磅)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acc14121561, createdName=xxxx1054, createdTime=Sun May 19 12:42:00 CST 2019, time=2019-05-19, status=1, ipAttribution=)]
    2019-05-19 xxxx1054

相关资讯

山东:医保个人账户实现省内异地使用

山东省医疗保障局表示,截至4月底,山东16地市之间已实现医保个人账户的互联互通。

长三角议事厅︱异地医保一体化如何优化?五个问题待解

2018年9月,长三角地区异地就医门诊直接结算试点启动,江苏省、浙江省和安徽省的8个统筹地区和上海市成为首批试点地区,这些地区的异地安置退休人员、异地长期居住人员、常驻异地工作人员及异地转诊人员等四类参保人员在试点医院门诊就医时,可以享受到跨省就医门诊费用直接结算的便利。据悉,近期长三角异地就医门诊直接结算又新增了9个试点地区。截至2019年4月,异地门诊直接结算总量已达3.3万人次,涉及门诊

《关于做好2019年城乡居民基本医疗保障工作的通知》政策解读

5月13日,为贯彻落实2019年《政府工作报告》任务要求,全面推进完善统一的城乡居民基本医疗保险和大病保险制度,国家医疗保障局会同财政部印发了《关于做好2019年城乡居民基本医疗保障工作的通知》(医保发﹝2019﹞30号,以下简称《通知》),同时公布了其相关内容的政策解读。

取消医保个人账户 会否激发更多医保资源浪费?

随着国家医保资金日渐吃紧,唤醒医保个人账户中沉睡的数千亿资金,乃至取消个人账户成为部分专家建议的救市良方。其能否从根本上逆转医保资金紧张困境,还是会激发更多、更大的医保资源浪费?

医保提高统筹层次带来的市场变革

随着老龄化和慢性病的增长,开支的增速持续超过收入的增速,医保的可持续性成为一个日益突出的问题。为了应对未来可能的危机,加强医保基金的筹资能力和控费能力是两个主要的手段。不过,由于原先医保管理主体的碎片化,无论是从筹资的力度还是控费的能力上都面临较大的压力。改变医保管理的碎片化并加强集中度就成为了最为现实的选择。

局长访谈:3个要点 实现基本医保制度“权利”与“义务”的对等

基本医疗保险要坚持参保人权利和义务对等的原则。